Weight loss pills, Ozempic's big fan, and Merck's skin cancer drug: Pharma news roundupByBruce GilPublishedMay 17, 2024
Eli Lilly says its experimental weekly insulin works just as well as daily dosesByBruce GilPublishedMay 16, 2024UpdatedYesterday
An experimental weight loss drug helped users lose 18% of their weight in an early trialByBruce GilUpdatedYesterday
A Chinese biotech company poised for the U.S. blacklist has registered to lobby CongressByBruce GilPublishedMay 16, 2024
Elon Musk’s Neuralink has known about problems with its brain chip implant for years, report saysByBruce GilPublishedMay 15, 2024
Pete Buttigieg is 'speechless' that airlines are suing to block rules against hidden feesByBruce GilUpdatedWednesday 10:57AM
A pill could solve the Zepbound and Wegovy shortage, Eli Lilly executive saysByBruce GilUpdatedWednesday 3:32PM
People taking the weight loss drug Wegovy are keeping the weight off for years, study saysByBruce GilPublishedMay 14, 2024
The owner of De Beers is spinning off the diamond brand as it fights a takeoverByBruce GilUpdatedTuesday 11:27AM
Johnson & Johnson is selling off its stake in the maker of Tylenol and Band-AidsByBruce GilPublishedMay 13, 2024
Merck stopped a clinical trial for its experimental skin cancer drug after a high rate of side effectsByBruce GilPublishedMay 13, 2024
Microsoft, Amazon, Pfizer, and others are investing a record $16 billion in FranceByBruce GilPublishedMay 13, 2024
The FTC is challenging 'junk' drug patents. Here's what they are and why they matterByBruce GilUpdatedMay 8, 2024
Amazon is about to start advertising Amazon products when Prime Video users hit pauseByBruce GilPublishedMay 8, 2024
Merck and other pharma giants are bracing for competition to their blockbuster drugs. Here's howByBruce GilUpdatedMay 8, 2024
